PROSER3: A Potential Drug Target and Biomarker (G148137)

Target Name: PROSER3

NCBI ID: G148137

PROSER3

PROSER3: A Potential Drug Target and Biomarker

Proline and serine-rich protein 3 (ISOform 1), also known as PROSER3, is a protein that has been identified as a potential drug target and biomarker. The protein is involved in various cellular processes, including cell signaling, DNA replication, and repair , making it an attractive target for drug development. Its function and unique structure make it an interesting candidate for drug intervention.

PROSER3: Structure and Function

PROSER3 is a protein that consists of 251 amino acids with a calculated molecular weight of 31 kDa. It has a unique structure, with a molecular weight of 31 kDa and a calculated pI of 9.6. The protein has a linear molecule with a single transmembrane region and a N-terminus. PROSER3 is a monomer and has one splice variant.

PROSER3 is involved in various cellular processes, including cell signaling, DNA replication, and repair. It plays a critical role in the regulation of DNA replication, as it is involved in the checkpoint system for DNA replication. The protein helps ensure that the double helix is replicated accurately, and any errors are repaired.

PROSER3 has also been shown to be involved in cell signaling. It has been shown to play a role in the regulation of T cell development and in the development of cancer. Additionally, PROSER3 has been linked to the regulation of cell adhesion, which is critical for the development of tissues and organs.

Drug Targeting

PROSER3 is a potential drug target due to its unique structure and function. The protein has a linear molecule and a single transmembrane region, making it easy to target using small molecules or antibodies. Additionally, its pI is well-defined, which makes it more susceptible to drug intervention.

Targeting PROSER3 may have potential therapeutic applications in various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. For example, targeting PROSER3 with small molecules or antibodies may be useful in treating cancer by inhibiting its role in cell signaling.

Biomarker

PROSER3 has also been identified as a potential biomarker for various diseases. Its involvement in cell signaling and DNA replication make it an attractive candidate for diagnostic applications. For example, measuring the levels of PROSER3 may be useful in monitoring the effectiveness of cancer treatments.

Conclusion

PROSER3 is a protein that has unique structure and function, making it an attractive candidate for drug intervention. Its involvement in various cellular processes, including cell signaling and DNA replication, makes it an attractive target for small molecules or antibodies. Additionally, its linear molecule and single transmembrane region make it easy to target, and its pI is well-defined, which makes it more susceptible to drug intervention.

Furthermore, PROSER3 has also been shown to play a critical role in the regulation of DNA replication and has been linked to the development of cancer. Its potential as a drug target and biomarker make it an interesting candidate for further research.

Overall, PROSER3 is a protein that has the potential to be a drug target and biomarker, with potential therapeutic applications in various diseases. Further research is needed to fully understand its function and develop effective treatments.

Protein Name: Proline And Serine Rich 3

The "PROSER3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PROSER3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets